1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	784_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	784_QUEST_clinical_caseMIR	SENT1	-	-
3	70	70		-	-	9-11	784_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	784_QUEST_clinical_caseMIR	SENT1	-	-
5	que	que	PR0CN000	-	-	17-20	784_QUEST_clinical_caseMIR	SENT1	-	-
6	acude	acudir	VMIP3S0	-	-	21-26	784_QUEST_clinical_caseMIR	SENT1	-	-
7	a	a	SPS00	-	-	27-28	784_QUEST_clinical_caseMIR	SENT1	-	-
8	urgencias	urgencia	NCFP000	C0439609	calificador	29-38	784_QUEST_clinical_caseMIR	SENT1	-	-
9	por	por	SPS00	C0678226	atributo	39-42	784_QUEST_clinical_caseMIR	SENT1	-	-
10	astenia	astenia	NCFS000	C0004093#C3714552	hallazgo	43-50	784_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
11	.	.	Fp	-	-	50-51	784_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	52-54	784_QUEST_clinical_caseMIR	SENT2	-	-
2	el	el	DA0MS0	-	-	55-57	784_QUEST_clinical_caseMIR	SENT2	-	-
3	examen	examen	NCMS000	C0031809_1	procedimiento_1	58-64	784_QUEST_clinical_caseMIR	SENT2	-	-
4	físico	físico	NCMS000	C0031809_2	procedimiento_2	65-71	784_QUEST_clinical_caseMIR	SENT2	-	-
5	destaca	destacar	VMIP3S0	-	-	72-79	784_QUEST_clinical_caseMIR	SENT2	-	-
6	palidez	palidez	NCFS000	C0030232#C1275397	hallazgo	80-87	784_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
7	cutáneomucosa	cutáneomucosa	NCFS000	-	-	88-101	784_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
8	con	con	SPS00	C0332287	atributo	102-105	784_QUEST_clinical_caseMIR	SENT2	-	-
9	subictericia	subictericia	NCFS000	-	-	106-118	784_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
10	conjuntival	conjuntival	AQ0CS0	-	-	119-130	784_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
11	y	y	CC	C1706368	calificador	131-132	784_QUEST_clinical_caseMIR	SENT2	-	-
12	un	un		C0205447_1	calificador_1	133-135	784_QUEST_clinical_caseMIR	SENT2	-	-
13	soplo	soplo	NCMS000	C0232258_1	hallazgo_1	136-141	784_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
14	pansistólico	pansistólico		C0232258_2	hallazgo_2	142-154	784_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
15	audible	audible	AQ0CS0	-	-	155-162	784_QUEST_clinical_caseMIR	SENT2	-	-
16	en	en	SPS00	C1720294#C0332285	calificador#atributo	163-165	784_QUEST_clinical_caseMIR	SENT2	-	-
17	todos	todo	DI0MP0	C0205197#C0439810#C0444868#C0444667	calificador	166-171	784_QUEST_clinical_caseMIR	SENT2	-	-
18	los	el	DA0MP0	-	-	172-175	784_QUEST_clinical_caseMIR	SENT2	-	-
19	focos	foco	NCMP000	-	-	176-181	784_QUEST_clinical_caseMIR	SENT2	-	-
20	.	.	Fp	-	-	181-182	784_QUEST_clinical_caseMIR	SENT2	-	-

1	Analíticamente	analíticamente	RG	-	-	183-197	784_QUEST_clinical_caseMIR	SENT3	-	-
2	destaca	destacar	VMIP3S0	-	-	198-205	784_QUEST_clinical_caseMIR	SENT3	-	-
3	hemoglobina	hemoglobina	NCFS000	C0019046	sustancia	206-217	784_QUEST_clinical_caseMIR	SENT3	-	-
4	8	8	Z	-	-	218-219	784_QUEST_clinical_caseMIR	SENT3	-	-
5	g	g	NCMN000	-	-	220-221	784_QUEST_clinical_caseMIR	SENT3	-	-
6	/	/	Fh	-	-	221-222	784_QUEST_clinical_caseMIR	SENT3	-	-
7	dl	decilitro	NCMN000	C0439241	calificador	222-224	784_QUEST_clinical_caseMIR	SENT3	-	-
8	,	,	Fc	-	-	224-225	784_QUEST_clinical_caseMIR	SENT3	-	-
9	VCM	vcm	NC00SC0	C0524587	entidad_observable	226-229	784_QUEST_clinical_caseMIR	SENT3	-	-
10	100	100		-	-	230-233	784_QUEST_clinical_caseMIR	SENT3	-	-
11	fl	fl	NC00SC0	C0475213	calificador	234-236	784_QUEST_clinical_caseMIR	SENT3	-	-
12	,	,	Fc	-	-	236-237	784_QUEST_clinical_caseMIR	SENT3	-	-
13	LDH	ldh	NC00SC0	C0022917	sustancia	238-241	784_QUEST_clinical_caseMIR	SENT3	-	-
14	900	900		-	-	242-245	784_QUEST_clinical_caseMIR	SENT3	-	-
15	U	o	CC	-	-	246-247	784_QUEST_clinical_caseMIR	SENT3	-	-
16	/	/	Fh	-	-	247-248	784_QUEST_clinical_caseMIR	SENT3	-	-
17	l	l	NCFS000	-	-	248-249	784_QUEST_clinical_caseMIR	SENT3	-	-
18	,	,	Fc	-	-	249-250	784_QUEST_clinical_caseMIR	SENT3	-	-
19	haptoglobina	haptoglobina	NCFS000	C0018595	sustancia	251-263	784_QUEST_clinical_caseMIR	SENT3	-	-
20	indetectable	indetectable	AQ0CS0	-	-	264-276	784_QUEST_clinical_caseMIR	SENT3	-	-
21	y	y	CC	C1706368	calificador	277-278	784_QUEST_clinical_caseMIR	SENT3	-	-
22	bilirrubina	bilirrubina	NCFS000	C0201913_1	procedimiento_1	279-290	784_QUEST_clinical_caseMIR	SENT3	-	-
23	total	total	NCMS000	C0201913_2	procedimiento_2	291-296	784_QUEST_clinical_caseMIR	SENT3	-	-
24	3.5	3.5	Z	-	-	297-300	784_QUEST_clinical_caseMIR	SENT3	-	-
25	mg	mg	NCMN000	-	-	301-303	784_QUEST_clinical_caseMIR	SENT3	-	-
26	/	/	Fh	-	-	303-304	784_QUEST_clinical_caseMIR	SENT3	-	-
27	dl	decilitro	NCMN000	C0439241	calificador	304-306	784_QUEST_clinical_caseMIR	SENT3	-	-
28	.	.	Fp	-	-	306-307	784_QUEST_clinical_caseMIR	SENT3	-	-

1	Se	se	P00CN000	-	-	308-310	784_QUEST_clinical_caseMIR	SENT4	-	-
2	solicitó	solicitar	VMIS3S0	-	-	311-319	784_QUEST_clinical_caseMIR	SENT4	-	-
3	la	el	DA0FS0	-	-	320-322	784_QUEST_clinical_caseMIR	SENT4	-	-
4	determinación	determinación	NCFS000	C0242485	procedimiento	323-336	784_QUEST_clinical_caseMIR	SENT4	-	-
5	de	de	SPS00	C0332285	atributo	337-339	784_QUEST_clinical_caseMIR	SENT4	-	-
6	una	una		C0205447_1	calificador_1	340-343	784_QUEST_clinical_caseMIR	SENT4	-	-
7	prueba	prueba	NCFS000	-	-	344-350	784_QUEST_clinical_caseMIR	SENT4	-	-
8	inmunohematológica	inmunohematológica	AQ0FS00	-	-	351-369	784_QUEST_clinical_caseMIR	SENT4	-	-
9	.	.	Fp	-	-	369-370	784_QUEST_clinical_caseMIR	SENT4	-	-

1	Señale	señalar	VMM03S0	-	-	371-377	784_QUEST_clinical_caseMIR	SENT5	-	-
2	la	el	DA0FS0	-	-	378-380	784_QUEST_clinical_caseMIR	SENT5	-	-
3	respuesta	respuesta	NCFS000	-	-	381-390	784_QUEST_clinical_caseMIR	SENT5	-	-
4	correcta	correcto	AQ0FS0	C0205170	calificador	391-399	784_QUEST_clinical_caseMIR	SENT5	-	-
5	.	.	Fp	-	-	399-400	784_QUEST_clinical_caseMIR	SENT5	-	-

